Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting-Reference-Cited by-同舟云学术

Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting

Author:

Krakowski I.¹²^ORCID,Bottai M.³,Häbel H.³,Masucci G.²⁴⁵,Girnita A.²⁴,Smedby K.E.⁶⁷,Eriksson H.²⁴⁵^ORCID

Affiliation:

1. Department of Dermatology/Theme inflammation Karolinska University Hospital Stockholm Sweden

2. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

3. Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

4. Skin Cancer Center Theme Cancer Karolinska University Hospital Stockholm Sweden

5. Department of Oncology/Theme Cancer Karolinska University Hospital Stockholm Sweden

6. Department of Medicine Solna Division of Clinical Epidemiology Karolinska Institutet Stockholm Sweden

7. Department of Medicine Solna Division of Hematology Karolinska University Hospital Stockholm Sweden

Funder

Cancerfonden

Svenska Läkaresällskapet

Radiumhemmets Forskningsfonder

Alex och Eva Wallströms Stiftelse för Vetenskaplig Forskning och Utbildning

Svenska Sällskapet för Medicinsk Forskning

Karolinska Institutet

Stockholms Läns Landsting

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

Reference35 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Dermatological Sequelae of COVID-19 Infection;Post COVID-19 Complications and Management;2022